Final results from a phase I trial and expansion cohorts of cabozantinib and nivolumab (CaboNivo) alone or with ipilimumab (CaboNivoIpi) for metastatic genitourinary tumors.

被引：6
|
作者：
Apolo, Andrea B. [1 ]
Girardi, da Motta Daniel [1 ]
Niglio, Scot Anthony [1 ]
Nadal, Rosa Maria [2 ]
Cordes, Lisa M. [2 ]
Steinberg, Seth M. [3 ]
Costello, Rene
Trepel, Jane B. [4 ]
Lee, Sunmin
Lee, Min-Jung [5 ]
Cao Liang [6 ]
Gulley, James L. [1 ]
Bottaro, Donald P. [7 ]
Saraiya, Biren [8 ,9 ]
Pal, Sumanta K. [10 ]
Quinn, David, I [11 ]
Lara, Primo Lucky N. [12 ]
Parnes, Howard L. [1 ]
Dahut, William L. [13 ]
Mortazavi, Amir [14 ]
机构：
[1] NCI, NIH, Bethesda, MD 20892 USA
[2] NIH, Bldg 10, Bethesda, MD 20892 USA
[3] NCI, Biostat & Data Management Sect, NIH, Bethesda, MD 20892 USA
[4] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
[5] NCI, Dev Therapeut Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
[6] NCI, Genet Branch, Ctr Canc Res, Bethesda, MD 20892 USA
[7] Ctr Canc Res, Div Canc Treatment & Diag, Bethesda, MD USA
[8] Rutgers Canc Inst New Jersey, Div Med Oncol, New Brunswick, NJ USA
[9] Rutgers Robert Wood Johnson Med Sch, New Brunswick, NJ USA
[10] City Hope Comprehens Canc Ctr, Dept Med Oncol & Therapeut, Duarte, CA USA
[11] USC Norris Canc Hosp, Los Angeles, CA USA
[12] Univ Calif, Sacramento, CA USA
[13] NCI, Bethesda, MD 20892 USA
[14] Ohio State Univ, Wexner Med Ctr, Arthur G James Canc Hosp, Columbus, OH 43210 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 06期
关键词：
D O I：
10.1200/JCO.2021.39.6_suppl.3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Final results from phase I trial of cabozantinib/nivolumab (CaboNivo) alone or with ipilimumab (CaboNivoIpi) and peripheral immunity in metastatic genitourinary (mGU) tumors
    Kydd, A. R.
    Lee, M-J.
    Lee, S.
    Rastogi, S.
    Sato, N.
    Cordes, L.
    Ley, L.
    Ortiz, O. Sierra
    Wright, J. J.
    Streicher, H.
    Steinberg, S.
    Saraiya, B.
    Pal, S. K.
    Lara, P. N.
    Mortazavi, A.
    Costello, R.
    Niglio, S.
    Bottaro, D.
    Trepel, J.
    Apolo, A. B.
    ANNALS OF ONCOLOGY, 2021, 32 : S690 - S690
  • [2] Final Results From a Phase I Trial and Expansion Cohorts of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced/Metastatic Genitourinary Tumors
    Apolo, Andrea B.
    Girardi, Daniel M.
    Niglio, Scot A.
    Nadal, Rosa
    Kydd, Andre R.
    Simon, Nicholas
    Ley, Lisa
    Cordes, Lisa M.
    Chandran, Elias
    Steinberg, Seth M.
    Lee, Sunmin
    Lee, Min-Jung
    Rastogi, Shraddha
    Sato, Nahoko
    Cao, Liang
    Banday, A. Rouf
    Boudjadi, Salah
    Merino, Maria J.
    Toubaji, Antoun
    Akbulut, Dilara
    Redd, Bernadette
    Bagheri, Hadi
    Costello, Rene
    Gurram, Sandeep
    Agarwal, Piyush K.
    Chalfin, Heather J.
    Valera, Vladimir
    Streicher, Howard
    Wright, John Joseph
    Sharon, Elad
    Figg, William D.
    Parnes, Howard L.
    Gulley, James L.
    Saraiya, Biren
    Pal, Sumanta K.
    Quinn, David
    Stein, Mark N.
    Lara, Primo N.
    Bottaro, Donald P.
    Mortazavi, Amir
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (25)
  • [3] A phase I study of cabozantinib plus nivolumab (CaboNivo) and ipilimumab (CaboNivoIpi) in patients (pts) with refractory metastatic urothelial carcinoma (mUC) and other genitourinary (GU) tumors.
    Apolo, Andrea B.
    Mortazavi, Amir
    Stein, Mark N.
    Pal, Sumanta K.
    Davarpanah, Nicole N.
    Parnes, Howard L.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [4] A phase I study of cabozantinib plus nivolumab (CaboNivo) and cabonivo plus ipilimumab (CaboNivoIpi) in patients (pts) with refractory metastatic (m) urothelial carcinoma (UC) and other genitourinary (GU) tumors.
    Apolo, Andrea B.
    Mortazavi, Amir
    Stein, Mark N.
    Davarpanah, Nicole N.
    Nadal, Rosa Maria
    Parnes, Howard L.
    Ning, Yangmin M.
    Francis, Deneise C.
    Cordes, Lisa M.
    Berniger, Marilise Anne
    Steinberg, Seth M.
    Agarwal, Piyush K.
    Bagheri, Mohammadhadi H.
    Nanda, Swati
    Monk, Paul
    Lancaster, Tiffany
    Moore, Tina
    Costello, Rene
    Bottaro, Donald P.
    Pal, Sumanta K.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [5] Ipilimumab challenge/re-challenge in metastatic urothelial carcinoma (mUC) and other genitourinary (GU) tumors treated with cabozantinib plus nivolumab (CaboNivo) or cabozantinib plus nivolumab plus ipilimumab (CaboNivoIpi).
    Niglio, Scot Anthony
    Girardi, Daniel Motta
    Mortazavi, Amir
    Lara, Primo
    Pal, Sumanta K.
    Saraiya, Biren
    Cordes, Lisa M.
    Ley, Lisa
    Ortiz, Olena Sierra
    Cadena, Jacqueline
    Diaz, Carlos
    Bagheri, Mohammadhadi H.
    Steinberg, Seth M.
    Costello, Rene
    Streicher, Howard
    Wright, John
    Parnes, Howard L.
    Ning, Yang-Min
    Bottaro, Donald P.
    Apolo, Andrea B.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [6] Phase I Study of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced or Metastatic Urothelial Carcinoma and Other Genitourinary Tumors
    Apolo, Andrea B.
    Nadal, Rosa
    Girardi, Daniel M.
    Niglio, Scot A.
    Ley, Lisa
    Cordes, Lisa M.
    Steinberg, Seth M.
    Sierra Ortiz, Olena
    Cadena, Jacqueline
    Diaz, Carlos
    Mallek, Marissa
    Davarpanah, Nicole N.
    Costello, Rene
    Trepel, Jane B.
    Lee, Min-Jung
    Merino, Maria J.
    Bagheri, Mohammad Hadi
    Monk, Paul
    Figg, William D.
    Gulley, James L.
    Agarwal, Piyush K.
    Valera, Vladimir
    Chalfin, Heather J.
    Jones, Jennifer
    Streicher, Howard
    Wright, John J.
    Ning, Yangmin M.
    Parnes, Howard L.
    Dahut, William L.
    Bottaro, Donald P.
    Lara, Primo N., Jr.
    Saraiya, Biren
    Pal, Sumanta K.
    Stein, Mark N.
    Mortazavi, Amir
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (31) : 3672 - +
  • [7] Results of phase I plus expansion cohorts of cabozantinib (Cabo) plus nivolumab (Nivo) and CaboNivo plus ipilimumab (Ipi) in patients (pts) with with metastatic urothelial carcinoma (mUC) and other genitourinary (GU) malignancies.
    Nadal, Rosa Maria
    Mortazavi, Amir
    Stein, Mark
    Pal, Sumanta K.
    Davarpanah, Nicole N.
    Parnes, Howard L.
    Ning, Yang-Min
    Cordes, Lisa M.
    Bagheri, Mohammadhadi H.
    Lindenberg, Liza
    Thompson, Ryan
    Steinberg, Seth M.
    Moore, Tina
    Lancaster, Tiffany
    Velez, Milisyaris
    Mena, Esther
    Costello, Rene
    Bottaro, Donald
    Dahut, William L.
    Apolo, Andrea B.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [8] Circulating tumor cell (CTC) enumeration in patients (pts) with metastatic genitourinary (mGU) tumors treated in a phase I study of cabozantinib and nivolumab (CaboNivo) plus /- ipilimumab (CaboNivolpi).
    Hu, Zishuo
    Mortazavi, Amir
    Pal, Sumanta K.
    Lara, Primo
    Mayer, Tina M.
    Steinberg, Seth M.
    Mayfield, Christian
    Graap, Katherine
    Mallek, Marissa
    Costello, Rene
    Diaz, Carlos
    Schonhoft, Joseph
    Wang, Yipeng
    Dittamore, Ryan
    Chu, Lincy
    Trepel, Jane B.
    Bottaro, Donald P.
    Apolo, Andrea B.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [9] Circulating tumor cell (CTC) enumeration in patients (pts) with metastatic genitourinary (mGU) tumors treated in a phase I study of cabozantinib and nivolumab (CaboNivo) plus /- ipilimumab (CaboNivolpi).
    Apolo, Andrea B.
    Mortazavi, Amir
    Hu, Zishuo Ian
    Schonhoft, Joseph
    Chu, Lincy
    Anderson, Amanda K. L.
    Wang, Yipeng
    Dittamore, Ryan
    Pal, Sumanta K.
    Lara, Primo
    Stein, Mark N.
    Steinberg, Seth M.
    Mayfield, Christian
    Cordes, Lisa M.
    Mallek, Marissa
    Costello, Rene
    Diaz, Carlos
    Trepel, Jane B.
    Bottaro, Donald P.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [10] Final results of a phase I study of cabozantinib (cabo) plus nivolumab (nivo) and cabonivo plus ipilimumab (Ipi) in patients (pts) with metastatic urothelial carcinoma (mUC) and other genitourinary (GU) malignancies
    Nadal, R.
    Mortazavi, A.
    Stein, M.
    Pal, S. K.
    Davarpanah, N.
    Parnes, H. L.
    Ning, Y. M.
    Cordes, L. M.
    Lin, J.
    Bagheri, M.
    Linderberg, L.
    Berniger, M.
    Steinberg, S. M.
    Moore, T.
    Lancaster, T.
    Aviles, M.
    Costello, R.
    Bottaro, D. P.
    Dahut, W. L.
    Apolo, A. B.
    ANNALS OF ONCOLOGY, 2017, 28
12345